North America CD28 Market: Rising Demand for Immune-Based Solutions
The North America CD28 market is expanding due to strong investment in immuno-oncology, autoimmune disease research, and advanced biopharmaceutical development. The region benefits from established research infrastructure and increasing development of CD28-targeted antibodies, fusion proteins, and other immune-modulating approaches. North America was identified as the largest regional market...
0 Commentaires 0 Parts 30 Vue 0 Aperçu